|
Cayman Chemical
cb6644 ![]() Cb6644, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cb-6644/bio_rxiv__2025__04__21__649771-254-0-1?v=Cayman+Chemical Average 90 stars, based on 1 article reviews
cb6644 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
MedKoo Inc
ruvbl1/2 inhibitor cb-6644 ![]() Ruvbl1/2 Inhibitor Cb 6644, supplied by MedKoo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cb-6644/pmc10265057-159-1-7?v=MedKoo+Inc Average 90 stars, based on 1 article reviews
ruvbl1/2 inhibitor cb-6644 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Chemdiv Inc
cb 6644 ![]() Cb 6644, supplied by Chemdiv Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cb-6644/pmc09034851-38-27-21?v=Chemdiv+Inc Average 86 stars, based on 1 article reviews
cb 6644 - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
CB-6644 is a selective inhibitor of RUVBL1/2 complex with anti-cancer activity. CB-6644 blocks the ATPase activity of RUVBL1/2 with an IC50 of 15 nM.
|
Buy from Supplier |
|
CB-6644 is a selective inhibitor of RUVBL1 / 2 complex with anti-cancer activity. CB-6644 blocks the ATPase activity of RUVBL1/2 with an IC 50 of 15 nM.In VitroCB-6644 (20 µM) interacts with the RUVBL1/2 complex
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: Early epigenetic priming of regeneration studied with a novel transgenic epigenetic reporter
doi: 10.1101/2025.04.21.649771
Figure Lengend Snippet: (A) Hybridization chain reaction (HCR) imaging shows co-localization of ruvbl1 and ruvbl2 transcripts (magenta) with GFPd2 (green). Scale bar, 100 μm. (B) Schematic representation of the Vivo-Morpholino (Vivo-MO) injection strategy in regenerating adult caudal fins. Regenerative growth was quantified at 3 dpa by comparing the injected region (Area I ) to the uninjected control region (Area U ) within the same fin. (C) Representative images of adult fins at 1 dpa (pre-injection) and at 3 dpa following injection with control, ruvbl1 , or ruvbl2 Vivo-MOs at 1 and 2 dpa. Knockdown of ruvbl1 or ruvbl2 resulted in reduced regenerative outgrowth. Scale bar, 0.5 mm. (D) Violin plots showing percent regenerative growth across different conditions (****p<0.0001; **p<0.01). (E) Schematic representation of larval tail regeneration inhibitor treatment strategy. Tails were amputated at 3 dpf and regeneration was monitored in the presence of Ruvbl1/2 inhibitor CB6644 from 0 to 4 dpa (3 to 7 dpf). (F) Representative images of regenerating larval tails treated with 1% DMSO (vehicle control) or CB6644 at 10, 25, or 50 μM. Scale bar, 100 μm. (G) Violin plots showing regenerative area (mm 2 ) across treatments (ns, not significant; *p<0.05; ****p<0.0001).
Article Snippet:
Techniques: Hybridization, Imaging, Injection, Control, Knockdown